Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T.
Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
B-Cell Targeting Agents in the Treatment of Multiple Sclerosis.
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes.
Future MRI tools in multiple sclerosis.
Multifocal Acquired Demyelinating Sensory and Motor Neuropathy: Unexpected Diagnosis After Ultrasound Imaging for a Humeral Fracture.
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target.
The activities and participation categories of the ICF Core Sets for multiple sclerosis from the patient perspective.
Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis.
Life on hold: the experience of living with neuromyelitis optica.
T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2.
Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways.
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Adolescent-onset Krabbe disease with an initial diagnosis of multiple sclerosis and a novel mutation.
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage.
Plasmablast in the pathology of multiple sclerosis.
Need for the upcoming revision of the current diagnostic criteria for NMO - response to the letter from Zhou et al.
Statins and Neuroprotection: Basic Pharmacology Needed.
A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci.
Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
Acute disseminated encephalomyelitis presenting as pyrexia of unknown origin.

Pages